PROTEIN MARKER NM23 OFFERS PROGNOSTIC INFORMATION IN
COLORECTAL CANCER PATIENTS Evaluation of the protein marker nm23 in patients
undergoing resection of colorectal cancer may help determine which patients
are most likely to develop liver metastases and could benefit from
adjuvant therapy, according to a report in the August issue of Annals of
Surgery. http://oncology.medscape.com/11472.rhtml
<a href="http://oncology.medscape.com/11472.rhtml">Read it
Here</a>
